Dr. John Thomas Maple II, DO

Dr. Maple practices at INTEGRIS Health Baptist Medical Center in Oklahoma City, Oklahoma, part of INTEGRIS Health.

Dr. Maple's NPI, 1902879455, was assigned on February 7, 2006. Dr. Maple graduated from Oklahoma State University College of Osteopathic Medicine in 2000. Dr. Maple holds Oklahoma license 4476.

Dr. Maple's primary practice is INTEGRIS Health Baptist Medical Center, at 3300 Northwest Expressway, Oklahoma City, OK 73112 in Oklahoma County. The practice phone is (405) 949-3011.

Dr. Maple's primary practice is INTEGRIS Health Baptist Medical Center in Oklahoma City, Oklahoma, part of INTEGRIS Health. Dr. Maple is also affiliated with INTEGRIS Health Southwest Medical Center. The medical group on file is OU Health. Dmand AI also links Dr. Maple to 3 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Maple practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Maple's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Maple is licensed in Oklahoma.

CMS data shows 518 Medicare services from Dr. Maple across 13 procedure codes in 2024, for 290 Medicare patients. Medicare paid $79,343 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 290 Medicare patients who saw Dr. Maple in 2024. The largest group is 65 to 74, with 137 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Maple's median patient age at 68, with 47% women.

In 2024, Dr. Maple wrote 148 Medicare Part D claims for 83 patients. 76% of them were for generic drugs. CMS names the drug for 91 of them, across 5 drugs with 11 or more claims each, at $848 in total drug cost. In 2022, CMS named 37 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Maple for performance year 2024, reported as part of a group. Dr. Maple accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 850 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Maple, more than 99% of the clinicians it reports for that procedure.

CMS Open Payments shows 45 general payments to Dr. Maple from 10 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $959.

Dr. Maple graduated from Oklahoma State University College of Osteopathic Medicine in 2000.